The Korean Academy of Tuberculosis and Respiratory Diseases Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT00864812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

fluticasone (cutivate) (1 trial)

salmeterol (serevent) (1 trial)

tiotropium (spiriva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3